• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊拉克心脏护理的一个里程碑:该国首例连续血流左心室辅助装置植入术后一年随访,为心脏移植铺平道路。

A Milestone in Cardiac Care in Iraq: One-year Follow-up after the Nation's First Continuous-flow Left Ventricular Assist Device Implantation, Paving the Way for Heart Transplantation.

作者信息

Merzah Ali Saad, Hanke Jasmin, Dogan Günes, Qahtan Salwan, Al-Hasnawi Saleh Mehdi, Faily Lukman, Ruhparwar Arjang, Schmitto Jan D

机构信息

Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Hannover, Germany.

Department of Cardiac Surgery, Nasiriyah Heart Center, Dhi Qar, Iraq.

出版信息

Heart Views. 2025 Jan-Mar;26(1):58-61. doi: 10.4103/heartviews.heartviews_20_25. Epub 2025 Jul 16.

DOI:10.4103/heartviews.heartviews_20_25
PMID:40851643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12370100/
Abstract

The first successful implantation of the HeartMate 3 LVAD in Iraq represents a transformative achievement in the nation's medical history. Conducted collaboratively by German and Iraqi teams in December 2023, the procedure addressed end-stage heart failure in a 60-year-old male. Despite significant healthcare challenges, the patient's functional status improved markedly, moving from New York Heart Association Class IV to Class I within a year. This groundbreaking case highlights the potential for Iraq to integrate advanced cardiac interventions into its healthcare system, paving the way for heart transplantation programs. Ongoing collaboration and investment in healthcare infrastructure will be pivotal for sustaining these innovations.

摘要

HeartMate 3左心室辅助装置在伊拉克的首次成功植入是该国医学史上的一项变革性成就。2023年12月,德国和伊拉克团队合作实施了该手术,治疗了一名60岁男性的终末期心力衰竭。尽管面临重大医疗挑战,但患者的功能状态显著改善,一年内从纽约心脏协会IV级提升至I级。这一开创性案例凸显了伊拉克将先进心脏干预措施纳入其医疗体系的潜力,为心脏移植项目铺平了道路。持续的合作以及对医疗基础设施的投资对于维持这些创新至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/827d/12370100/ce14141ac015/HV-26-58-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/827d/12370100/ce14141ac015/HV-26-58-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/827d/12370100/ce14141ac015/HV-26-58-g001.jpg

相似文献

1
A Milestone in Cardiac Care in Iraq: One-year Follow-up after the Nation's First Continuous-flow Left Ventricular Assist Device Implantation, Paving the Way for Heart Transplantation.伊拉克心脏护理的一个里程碑:该国首例连续血流左心室辅助装置植入术后一年随访,为心脏移植铺平道路。
Heart Views. 2025 Jan-Mar;26(1):58-61. doi: 10.4103/heartviews.heartviews_20_25. Epub 2025 Jul 16.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.左心室辅助装置作为晚期心力衰竭的终末期治疗的临床和成本效益:系统评价和经济评估。
Health Technol Assess. 2024 Aug;28(38):1-237. doi: 10.3310/MLFA4009.
4
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.终末期心力衰竭患者使用左心室辅助装置的临床疗效及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. doi: 10.3310/hta9450.
5
Evaluation of the ventricular assist device programme in the UK.英国心室辅助装置项目评估
Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. doi: 10.3310/hta10480.
6
Cardiac Surgery心脏外科手术
7
Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.第二代和第三代左心室辅助装置作为适合心脏移植的成人移植桥接或替代治疗的临床效果和成本效益:系统评价和成本效益模型。
Health Technol Assess. 2013 Nov;17(53):1-499, v-vi. doi: 10.3310/hta17530.
8
A Novel Numerical Study on the Development and Implementation of a Physiological Control Strategy for HeartMate 3 LVAD.关于HeartMate 3左心室辅助装置生理控制策略开发与实施的新型数值研究
Artif Organs. 2025 Aug 21. doi: 10.1111/aor.15052.
9
Is There an Association Between Living in a Rural Area and the Incidence of Postoperative Complications or Hospital Readmissions Following Left Ventricular Assist Device (LVAD) Implantation, Compared to Urban Lvad Recipients? A Systematic Review.与城市左心室辅助装置(LVAD)接受者相比,农村地区居民在LVAD植入术后的并发症发生率或再次入院率之间是否存在关联?一项系统评价。
Clin Cardiol. 2025 Jan;48(1):e70068. doi: 10.1002/clc.70068.
10
Readmission and Temporal Trends of Post-LVAD Placement Complications in Patients With End-Stage Heart Failure.终末期心力衰竭患者左心室辅助装置植入术后并发症的再入院情况及时间趋势
Artif Organs. 2025 Jul;49(7):1197-1206. doi: 10.1111/aor.14989. Epub 2025 Mar 19.

本文引用的文献

1
Advanced heart failure therapies in the Eastern Mediterranean Region: current status, challenges, and future directions.中东地中海地区的心力衰竭先进治疗方法:现状、挑战和未来方向。
Curr Probl Cardiol. 2024 Jul;49(7):102564. doi: 10.1016/j.cpcardiol.2024.102564. Epub 2024 Apr 8.
2
Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry.全磁悬浮离心式左心室辅助装置与长期预后:ELEVATE 注册研究。
Eur Heart J. 2024 Feb 21;45(8):613-625. doi: 10.1093/eurheartj/ehad658.
3
Outcomes of modular cable exchange in HeartMate 3 patients versus conventional driveline repair in HeartMate II patients.
HeartMate 3患者模块化电缆更换与HeartMate II患者传统驱动线修复的结果对比。
Artif Organs. 2023 Feb;47(2):380-386. doi: 10.1111/aor.14413. Epub 2022 Oct 8.
4
Five-year outcomes of patients supported with HeartMate 3: a single-centre experience.植入 HeartMate 3 患者的 5 年结果:单中心经验。
Eur J Cardiothorac Surg. 2021 Jun 14;59(6):1155-1163. doi: 10.1093/ejcts/ezab018.
5
Cardio-microcurrent device for chronic heart failure: first-in-human clinical study.用于慢性心力衰竭的心脏微电流装置:首次人体临床研究。
ESC Heart Fail. 2021 Apr;8(2):962-970. doi: 10.1002/ehf2.13242. Epub 2021 Feb 9.
6
First 5-year multicentric clinical trial experience with the HeartMate 3 left ventricular assist system.使用HeartMate 3左心室辅助系统的首个5年多中心临床试验经验。
J Heart Lung Transplant. 2021 Apr;40(4):247-250. doi: 10.1016/j.healun.2021.01.001. Epub 2021 Jan 8.
7
First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III).新型磁悬浮左心室辅助装置(HeartMate III)首次应用于人体植入。
J Heart Lung Transplant. 2015 Jun;34(6):858-60. doi: 10.1016/j.healun.2015.03.001. Epub 2015 Mar 7.